EndLyz Therapeutics is a startup based in the United Kingdom, most recent round Seed, 2 tracked investors.
Based in the United Kingdom, EndLyz Therapeutics is a startup founded in 2019. Its most recent tracked round is Seed. Brouky records 2 investors associated with the company.
EndLyz Therapeutics is a UK-based biotech company developing novel therapeutics for the treatment of neurodegenerative diseases. They focus on conditions such as Alzheimer's, Parkinson's, and Huntington's diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.